NPR’s All Things Considered discusses latest HD clinical trial on May 11. Listen or read more here.
Roche Phase 3 Clinical Trial for Huntington’s Disease Gene-Silencing Drug to Enroll Volunteers – Early 2019
Dear friends in the fight against Huntington's disease,
Pharma giant Roche expects to start enrolling subjects worldwide (including the U.S.) in early 2019 in its historic...